about
Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinomaMetastatic transcriptional pattern revealed by gene expression profiling in primary colorectal carcinoma.Kinase substrate protein microarray analysis of human colon cancer and hepatic metastasis.Matrix-comparative genomic hybridization from multicenter formalin-fixed paraffin-embedded colorectal cancer tissue blocks.Serum proteomic analysis identifies a highly sensitive and specific discriminatory pattern in stage 1 breast cancer.Multiplexed cell signaling analysis of human breast cancer applications for personalized therapy.Multiplexed Cell Signaling Analysis of Metastatic and Nonmetastatic Colorectal Cancer Reveals COX2-EGFR Signaling Activation as a Potential Prognostic Pathway Biomarker.Serum S100A6 concentration predicts peritoneal tumor burden in mice with epithelial ovarian cancer and is associated with advanced stage in patients.Investigation of the ovarian and prostate cancer peptidome for candidate early detection markers using a novel nanoparticle biomarker capture technology.Low level of p27(Kip1) protein expression in gastric adenocarcinoma is associated with disease progression and poor outcome.Multiplexed protein signal pathway mapping identifies patients with rectal cancer that responds to neoadjuvant treatment.A pilot characterization of human lung NSCLC by protein pathway activation mapping.Long-term outcome of patients with complete pathologic response after neoadjuvant chemoradiation for cT3 rectal cancer: implications for local excision surgical strategiesRatio between metastatic and examined lymph nodes is an independent prognostic factor after D2 resection for gastric cancer: analysis of a large European monoinstitutional experience.Mapping molecular networks using proteomics: a vision for patient-tailored combination therapy.Extended lymphadenectomy (D2) in patients with early gastric cancer.Predictive role of microRNA-related genetic polymorphisms in the pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients.Individualized therapy for metastatic colorectal cancer.Optimizing treatment of hepatic metastases from colorectal cancer: Resection or resection plus ablation?Interleukin 12 gene polymorphisms enhance gastric cancer risk in H pylori infected individuals.Pro- and anti-inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome.The blood peptidome: a higher dimension of information content for cancer biomarker discovery.Prostate carcinoma and green tea: PSA-triggered basement membrane degradation and MMP-2 activation are inhibited by (-)epigallocatechin-3-gallate.Association of p53 polymorphisms and colorectal cancer: modulation of risk and progression.Overexpression of squamous cell carcinoma antigen variants in hepatocellular carcinoma.Association between MDM2-SNP309 and age at colorectal cancer diagnosis according to p53 mutation status.Functional categories of TP53 mutation in colorectal cancer: results of an International Collaborative Study.Laparoscopic Placement of Adjustable Silicone Gastric Banding: Early Experience.Gene expression profile of primary gastric cancer: towards the prediction of lymph node status.Protein pathway biomarker analysis of human cancer reveals requirement for upfront cellular-enrichment processing.Elevated platelet count is a negative predictive and prognostic marker in locally advanced rectal cancer undergoing neoadjuvant chemoradiation: a retrospective multi-institutional study on 965 patientsNanotechnology in clinical proteomicsOncogene expression in follicular neoplasms of the thyroidPrognostic factors in node-negative breast cancerSignificance of serum ferritin in patients with gastric and colorectal cancerThe value of flow cytometric analysis in patients with gastric cancerDifferential oncogenic expression in thyroid follicular and Hürthle cell carcinomasStoma Adjustable Silicone Gastric Banding: Results in 111 Consecutive PatientsAdjustable Silicone Gastric Banding (ASGB): the Italian experienceAbsence of the cell cycle inhibitor p27Kip1 protein predicts poor outcome in patients with stage I-III colorectal cancer
P50
Q24645168-D782B825-9A80-451C-AECE-E48EF252D1DDQ31145803-6B9E9E55-CA2B-4759-956F-2B379A92E36FQ33215972-4CB5AA77-089E-42B9-B148-4A6A46B7571CQ33281073-2BEAE5ED-AEDD-458C-96D5-BBA35D8EF5DFQ33288983-AB101617-7A80-42A6-8063-9F8CB25C12A4Q33318685-650EE791-CE05-4E43-9705-2259000B7BE7Q33441095-4A52C510-2DDD-40D0-A8B7-15C04673ADB9Q33514817-DD80AC1D-4FC2-4B2C-8C1F-EEA559610801Q33605010-E1D74821-B132-44C1-9F00-7D9074627C7FQ34160896-A69A89B9-54D8-41BA-840B-EDFCBF15D55BQ34289736-4AFD2FFF-B4C6-4AC0-91DF-0FA6DF9F3D0FQ34478770-31622772-9AA7-4518-A341-6D9BEC74B71BQ35569457-74B41E49-486B-4084-A996-70BF002DAB65Q35575444-F5B38A8A-E45C-426B-B0E4-E4BA30EE9796Q36134724-FBF8949F-55ED-4C1D-AC42-A35870BA5BDDQ36211302-2A366339-AE43-4CEB-88B0-EA6443699844Q37190172-27028C8E-DE25-431C-B148-0AC4EFF94A37Q38092886-8134FB20-CF15-400B-BCF3-2A1AA57A50D2Q40091575-EDB36BDE-7AD1-42F7-B7C8-3C783ED3ECB4Q43073246-8CFE7B47-7698-4298-A9FD-8721A48E2CE4Q44001939-C56CE0BA-EBC4-46DB-AE42-55A60152B4E9Q44924621-7EC6BD84-F5DC-4B29-B173-FCF992629C71Q45073506-F0EAD1F9-00A9-4B68-9B2F-541CF3B550AAQ46603274-871589CC-264D-45E7-94BB-2CC0FD52DC8CQ46766358-A2AFCAD2-5188-4827-AB98-EEBE331C4C37Q46944917-EA0DB07D-A915-4D4A-A8F6-E168A4644B14Q46981343-7341C4C1-5524-4B82-9A35-33CA15DCB6ECQ54014259-B263061F-1E7E-44A9-884B-201F92EAAA37Q54571476-A17F9708-184C-4F56-8B2D-0D5820608115Q54689509-E18DB68E-BC4D-441A-AE1F-0A3D35C61E5FQ59127393-24B6AEFB-69B6-4A9B-8A86-72C0C4C971CCQ60614508-654CF7A7-4E7F-4374-9917-94819BA18DA7Q67524805-F5DED686-4FEA-474E-9F11-6BAE0CE3F8BEQ67526955-5FB452CF-23DF-4240-A1B7-223C6BABE7D2Q69421765-8B8CFAF7-9338-4162-A5FC-AD6F573D74D3Q70584016-8FD9A164-C0ED-4AAC-9BBB-31CAFCEDF55AQ72542958-D493739F-B626-47F1-82F8-3D0BE207CD0FQ73609386-AC88B648-9498-41AC-A558-0DA39E7843BBQ73659886-A9EAAAC1-FCB0-440E-AB0A-AD93469078FDQ74464755-FE04CB5C-1946-4A3B-A004-B97C01B73A78
P50
description
hulumtues
@sq
onderzoeker
@nl
researcher
@en
հետազոտող
@hy
name
Claudio Belluco
@ast
Claudio Belluco
@en
Claudio Belluco
@es
Claudio Belluco
@nl
Claudio Belluco
@sl
type
label
Claudio Belluco
@ast
Claudio Belluco
@en
Claudio Belluco
@es
Claudio Belluco
@nl
Claudio Belluco
@sl
prefLabel
Claudio Belluco
@ast
Claudio Belluco
@en
Claudio Belluco
@es
Claudio Belluco
@nl
Claudio Belluco
@sl
P106
P1153
6701610645
P21
P31
P496
0000-0001-5972-9574